Literature DB >> 27130346

Management of diabetes in Indigenous communities: lessons from the Australian Aboriginal population.

H D Nguyen1, S Chitturi1, L J Maple-Brown2,3.   

Abstract

Type 2 diabetes mellitus and other chronic cardio-metabolic conditions are significant contributors to the large disparities in life expectancy between Indigenous and non-Indigenous Australians. Type 2 diabetes is more prevalent from a young age among Indigenous Australians and is often preceded by a cluster of risk factors, including central obesity, dyslipidaemia, albuminuria and socio-economic disadvantage. Management of type 2 diabetes in Australian Indigenous peoples can be challenging in the setting of limited resources and socio-economic disadvantage. Key strategies to address these challenges include working in partnership with patients, communities and primary healthcare services (PHC, Aboriginal community controlled and government services) and working in a multidisciplinary team. Population prevention measures are required within and beyond the health system, commencing as early as possible in the life course.
© 2016 Royal Australasian College of Physicians.

Entities:  

Keywords:  Aboriginal; Indigenous Australians; cardio-metabolic; diabetes; diabetes management

Mesh:

Year:  2016        PMID: 27130346     DOI: 10.1111/imj.13123

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  3 in total

1.  Exploring the antidiabetic potential of compounds isolated from Anacardium occidentale using computational aproach: ligand-based virtual screening.

Authors:  Victor Okoliko Ukwenya; Sunday Aderemi Adelakun; Olusola Olalekan Elekofehinti
Journal:  In Silico Pharmacol       Date:  2021-04-03

2.  Invisible or high-risk: Computer-assisted discourse analysis of references to Aboriginal and Torres Strait Islander people(s) and issues in a newspaper corpus about diabetes.

Authors:  Monika Bednarek
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

3.  All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study.

Authors:  Yuejen Zhao; Kanakamani Jeyaraman; Paul Burgess; Christine Connors; Steven Guthridge; Louise Maple-Brown; Henrik Falhammar
Journal:  BMJ Open       Date:  2020-01-02       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.